A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia
Abstract Pathogen clearance and resolution of inflammation in patients with pneumonia require an effective local T cell response. Nevertheless, local T cell activation may drive lung injury, particularly during prolonged episodes of respiratory failure characteristic of severe SARS-CoV-2 pneumonia. While T cell responses in the peripheral blood are well described, the evolution of T cell phenotypes and molecular signatures in the distal lung of patients with severe pneumonia caused by SARS-CoV-2 or other pathogens is understudied. Accordingly, we serially obtained 432 bronchoalveolar lavage fluid samples from 273 patients with severe pneumonia and respiratory failure, including 74 unvaccinated patients with COVID-19, and performed flow cytometry, transcriptional, and T cell receptor profiling on sorted CD8+and CD4+T cell subsets. In patients with COVID-19 but not pneumonia secondary to other pathogens, we found that early and persistent enrichment in CD8+and CD4+T cell subsets correlated with survival to hospital discharge. Activation of interferon signaling pathways early after intubation for COVID-19 was associated with favorable outcomes, while activation of NF-κB-driven programs late in disease was associated with poor outcomes. Patients with SARS-CoV-2 pneumonia whose alveolar T cells preferentially targeted the Spike and Nucleocapsid proteins tended to experience more favorable outcomes than patients whose T cells predominantly targeted the ORF1ab polyprotein complex. These results suggest that in patients with severe SARS-CoV-2 pneumonia, alveolar T cell interferon responses targeting structural SARS-CoV-2 proteins characterize patients who recover, yet these responses progress to NF-κB activation against non-structural proteins in patients who go on to experience poor clinical outcomes..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 18. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Markov, Nikolay S. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.12.13.571479 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI041876725 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI041876725 | ||
| 003 | DE-627 | ||
| 005 | 20231219091123.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231215s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.12.13.571479 |2 doi | |
| 035 | |a (DE-627)XBI041876725 | ||
| 035 | |a (biorXiv)10.1101/2023.12.13.571479 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Markov, Nikolay S. |e verfasserin |0 (orcid)0000-0002-3659-4387 |4 aut | |
| 245 | 1 | 0 | |a A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Pathogen clearance and resolution of inflammation in patients with pneumonia require an effective local T cell response. Nevertheless, local T cell activation may drive lung injury, particularly during prolonged episodes of respiratory failure characteristic of severe SARS-CoV-2 pneumonia. While T cell responses in the peripheral blood are well described, the evolution of T cell phenotypes and molecular signatures in the distal lung of patients with severe pneumonia caused by SARS-CoV-2 or other pathogens is understudied. Accordingly, we serially obtained 432 bronchoalveolar lavage fluid samples from 273 patients with severe pneumonia and respiratory failure, including 74 unvaccinated patients with COVID-19, and performed flow cytometry, transcriptional, and T cell receptor profiling on sorted CD8+and CD4+T cell subsets. In patients with COVID-19 but not pneumonia secondary to other pathogens, we found that early and persistent enrichment in CD8+and CD4+T cell subsets correlated with survival to hospital discharge. Activation of interferon signaling pathways early after intubation for COVID-19 was associated with favorable outcomes, while activation of NF-κB-driven programs late in disease was associated with poor outcomes. Patients with SARS-CoV-2 pneumonia whose alveolar T cells preferentially targeted the Spike and Nucleocapsid proteins tended to experience more favorable outcomes than patients whose T cells predominantly targeted the ORF1ab polyprotein complex. These results suggest that in patients with severe SARS-CoV-2 pneumonia, alveolar T cell interferon responses targeting structural SARS-CoV-2 proteins characterize patients who recover, yet these responses progress to NF-κB activation against non-structural proteins in patients who go on to experience poor clinical outcomes. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Ren, Ziyou |0 (orcid)0000-0001-7127-4197 |4 aut | |
| 700 | 1 | |a Senkow, Karolina J. |0 (orcid)0000-0001-9942-3529 |4 aut | |
| 700 | 1 | |a Grant, Rogan A. |0 (orcid)0000-0003-0655-0882 |4 aut | |
| 700 | 1 | |a Gao, Catherine A. |0 (orcid)0000-0001-5576-3943 |4 aut | |
| 700 | 1 | |a Malsin, Elizabeth S. |0 (orcid)0000-0002-3294-6752 |4 aut | |
| 700 | 1 | |a Sichizya, Lango |0 (orcid)0000-0002-1704-9471 |4 aut | |
| 700 | 1 | |a Kihshen, Hermon |0 (orcid)0000-0002-8750-0010 |4 aut | |
| 700 | 1 | |a Helmin, Kathryn A. |4 aut | |
| 700 | 1 | |a Jovisic, Milica |4 aut | |
| 700 | 1 | |a Arnold, Jason M. |0 (orcid)0000-0001-8687-0063 |4 aut | |
| 700 | 1 | |a Pérez-Leonor, Xóchitl G. |4 aut | |
| 700 | 1 | |a Abdala-Valencia, Hiam |0 (orcid)0000-0003-3384-5299 |4 aut | |
| 700 | 1 | |a Swaminathan, Suchitra |0 (orcid)0000-0002-8292-122X |4 aut | |
| 700 | 1 | |a Nwaezeapu, Julu |4 aut | |
| 700 | 1 | |a Kang, Mengjia |0 (orcid)0000-0002-1679-9473 |4 aut | |
| 700 | 1 | |a Rasmussen, Luke |4 aut | |
| 700 | 1 | |a Ozer, Egon A. |0 (orcid)0000-0002-7131-3691 |4 aut | |
| 700 | 1 | |a Lorenzo-Redondo, Ramon |0 (orcid)0000-0002-5462-9483 |4 aut | |
| 700 | 1 | |a Hultquist, Judd F. |0 (orcid)0000-0001-6424-4280 |4 aut | |
| 700 | 1 | |a Simons, Lacy M. |0 (orcid)0000-0003-4041-6775 |4 aut | |
| 700 | 1 | |a Rios-Guzman, Estefany |0 (orcid)0000-0002-1399-7546 |4 aut | |
| 700 | 1 | |a Misharin, Alexander V. |0 (orcid)0000-0003-2879-3789 |4 aut | |
| 700 | 1 | |a Wunderink, Richard G. |0 (orcid)0000-0002-8527-4195 |4 aut | |
| 700 | 1 | |a Budinger, G.R. Scott |0 (orcid)0000-0002-3114-5208 |4 aut | |
| 700 | 1 | |a Singer, Benjamin D. |0 (orcid)0000-0001-5775-8427 |4 aut | |
| 700 | 1 | |a Morales-Nebreda, Luisa |0 (orcid)0000-0002-7126-0518 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 18. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:18 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.12.13.571479 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 18 |c 12 | ||